Home / Recalls / Nephron Sc Inc / D-0175-2023

D-0175-2023 Class II Terminated

Recalled by Nephron Sc Inc — West Columbia, SC

FDA drug recall D-0175-2023 was initiated by Nephron Sc Inc on Jan 13, 2023 and is designated Class II. Reason for recall: Short Fill The recall status is terminated (terminated Oct 11, 2024). Affected quantity: 387,000 vials.

Recall Details

Product Type: Drugs
Report Date: Feb 1, 2023
Initiation Date: Jan 13, 2023
Termination Date: Oct 11, 2024
Voluntary/Mandated: Voluntary: Firm initiated
Product Quantity: 387,000 vials

Product Description

Asthmanefrin Racepinephrine Inhalation Solution Bronchodilator (racephedrine, USP 11.25), 30x0.5 mL Sterile Vials each in a foil pouch, NDC 0487-2784-01 UPC 3 04872 78401 4

Reason for Recall

Short Fill

Distribution Pattern

Nationwide within the United States including Puerto Rico. Guatamala

Code Information

Lot #: 126451 Exp. 04/30/2023

Source

Dataset: openFDA drug recall enforcement reports
FDA record: This recall in openFDA (JSON)
Enforcement Report: Search FDA's Enforcement Report for D-0175-2023
openFDA file date: Nov 3, 2026
Loaded by RegDataLab: Nov 4, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Other recalls by Nephron Sc Inc

D-0479-2026 Class II — Albuterol Sulfate Inhalation Solution, 0.5%, 25 mg/5 mL (5 mg/mL*), 30x5 mL… (Mar 17, 2026)
D-0364-2023 Class II — Sterile Water for Injection, USP, 30x5 mL Single-Dose Vials, Rx Only, Nephron… (Feb 23, 2023)
D-0176-2023 Class II — S2 Racepinephrine Inhalation Solution, USP 2.25% Bronchodilator 30x0.5 mL… (Jan 13, 2023)
D-0177-2023 Class II — 0.9% Sodium Chloride Injection, USP, 100 mL Single-Dose Container bag, Rx Only… (Jan 12, 2023)
D-0178-2023 Class II — Sterile Water for Injection, USP, For Drug Diluent Use Only, 5 mL Single-Dose… (Jan 12, 2023)
D-1354-2022 Class II — Ketorolac Tromethamine Injection, USP 60 mg/2 mL (30 mg/mL), packaged in 2 mL… (Aug 10, 2022)